Prevalence of CADASIL and Fabry Disease in a Cohort of MRI Defined Younger Onset Lacunar Stroke

被引:33
|
作者
Kilarski, Laura L. [1 ]
Rutten-Jacobs, Loes C. A. [2 ]
Bevan, Steve [2 ]
Baker, Rob [3 ,4 ]
Hassan, Ahamad [5 ]
Hughes, Derralynn A. [3 ,4 ]
Markus, Hugh S. [2 ]
机构
[1] St Georges Univ London, Stroke & Dementia Res Ctr, London, England
[2] Univ Cambridge, Dept Clin Neurosci, Cambridge, England
[3] Royal Free Hosp, Dept Haematol, Lysosomal Storage Disorders Unit, London NW3 2QG, England
[4] UCL, Sch Med, London W1N 8AA, England
[5] Leeds Gen Infirm, Dept Neurol, Leeds, W Yorkshire, England
来源
PLOS ONE | 2015年 / 10卷 / 08期
基金
英国惠康基金;
关键词
CRYPTOGENIC ISCHEMIC-STROKE; NOTCH3; GENE; CEREBROVASCULAR-DISEASE; SIGNAL HYPERINTENSITIES; KOREAN PATIENTS; FAMILY-HISTORY; MUTATIONS; SUBTYPES; TIA;
D O I
10.1371/journal.pone.0136352
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and Purpose Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), caused by mutations in the NOTCH3 gene, is the most common monogenic disorder causing lacunar stroke and cerebral small vessel disease (SVD). Fabry disease (FD) due to mutations in the GLA gene has been suggested as an underdiagnosed cause of stroke, and one feature is SVD. Previous studies reported varying prevalence of CADASIL and FD in stroke, likely due to varying subtypes studied; no studies have looked at a large cohort of younger onset SVD. We determined the prevalence in a well- defined, MRI- verified cohort of apparently sporadic patients with lacunar infarct. Methods Caucasian patients with lacunar infarction, aged <= 70 years (mean age 56.7 (SD8.6)), were recruited from 72 specialist stroke centres throughout the UK as part of the Young Lacunar Stroke DNA Resource. Patients with a previously confirmed monogenic cause of stroke were excluded. All MRI's and clinical histories were reviewed centrally. Screening was performed for NOTCH3 and GLA mutations. Results Of 994 subjects five had pathogenic NOTCH3 mutations (R169C, R207C, R587C, C1222G and C323S) all resulting in loss or gain of a cysteine in the NOTCH3 protein. All five patients had confluent leukoaraiosis (Fazekas grade >= 2). CADASIL prevalence overall was 0.5% (95% CI 0.2%- 1.1%) and among cases with confluent leukoaraiosis 1.5% (95% CI 0.6%- 3.3%). No classic pathogenic FD mutations were found; one patient had a missensemutation (R118C), associated with late-onset FD. Conclusion CADASIL cases are rare and only detected in SVD patients with confluent leukoaraiosis. No definite FD cases were detected.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Detection of asymptomatic lacunar infarcts with diffusion weighted MRI: A potential surrogate marker of disease activity in ischaemic leukoaraiosis and CADASIL
    O'Sullivan, M
    Rich, PM
    Barrick, TR
    Clark, CA
    Markus, HS
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (02): : 220 - 220
  • [22] The prevalence of gallstone disease in a defined cohort of patients with Crohn's disease
    Lapidus, A
    Bångstad, M
    Åström, M
    Muhrbeck, O
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (05): : 1261 - 1266
  • [23] Clinical-MRI correlations in a multiethnic cohort with recent lacunar stroke: the SPS3 trial
    Benavente, Oscar R.
    Pearce, Lesly A.
    Bazan, Carlos
    Roldan, Ana M.
    Catanese, Luciana
    Livezey, Viveca M. Bhat
    Vidal-Pergola, Gabriela
    McClure, Leslie A.
    Hart, Robert G.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2014, 9 (08) : 1057 - 1064
  • [24] Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy
    Monserrat, Lorenzo
    Gimeno-Blanes, Juan Ramon
    Marin, Francisco
    Hermida-Prieto, Manuel
    Garcia-Honrubia, Antonio
    Perez, Inmaculada
    Fernandez, Xusto
    de Nicolas, Rosario
    de la Morena, Gonzalo
    Paya, Eduardo
    Yague, Jordi
    Egido, Jess
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (25) : 2399 - 2403
  • [25] Prevalence of Fabry disease in a cohort of 479 unrelated patients with hypertrophic cardiomyopathy
    Monserrat, L.
    Gimeno-Blanes, J. R.
    Marin-Ortuno, F.
    Gonzalez-Cabrero, J.
    Hermida-Prieto, M.
    Garcia-Honrubia, A.
    Perez, I.
    Fernandez, X.
    de la Morena, G.
    Paya, E.
    Yague, J.
    Egido, J.
    [J]. CLINICAL THERAPEUTICS, 2007, 29 : S23 - S24
  • [26] Zurich Fabry study - prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA
    Sarikaya, H.
    Yilmaz, M.
    Michael, N.
    Miserez, A. R.
    Steinmann, B.
    Baumgartner, R. W.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (11) : 1421 - 1426
  • [27] Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy
    Chimenti, C
    Pieroni, M
    Morgante, E
    Antuzzi, D
    Russo, A
    Russo, MA
    Maseri, A
    Frustaci, A
    [J]. CIRCULATION, 2004, 110 (09) : 1047 - 1053
  • [28] Response to Letter Regarding Belgian Fabry Study: Prevalence of Fabry Disease in a Cohort of 1000 Young Patients With Cerebrovascular Disease
    Brouns, Raf
    Thijs, Vincent
    Eyskens, Francois
    De Deyn, Peter Paul
    [J]. STROKE, 2011, 42 (01) : E6 - E7
  • [29] Searching for fabry disease in previously diagnosed cis and defined ms patients: a cohort study
    Fronza, M.
    Sunda, E.
    Lorefice, L.
    Coghe, G.
    Fenu, G.
    Musu, L.
    Spinicci, G.
    Cocco, E.
    Frau, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 247 - 247
  • [30] BELGIAN FABRY STROKE STUDY (BEFAS): A NATIONAL MULTI-CENTER PROSPECTIVE STUDY ON THE PREVALENCE OF FABRY DISEASE IN YOUNG PATIENTS WITH STROKE
    Eyskens, F. J.
    De Deyn, P. P.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 1 - 2